Aspirin/Carisoprodol/Codeine Phosphate

阿司匹林/卡立普多/磷酸可待因

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Carisoprodol/Codeine Phosphate
Drug Alias Name卡立普多磷酸可待因阿司匹林Carisoprodol/Codeine Phosphate/Aspirinacetylsalicylic acid/Carisoprodol/Codeine Phosphate磷酸可待因阿司匹林卡立普多Aspirin and Carisoprodol and Codeine Phosphate +[10] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsOpioid receptors agonists
TargetsOpioid receptorsCyclooxygenases
Therapy Area/IndicationsMusculoskeletal Pain
Global Approved IndicationsMusculoskeletal Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/10/05
Country/TerritoryUnited States
CombinationsYes CarisoprodolAspirinCodeine Phosphate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeda Ab
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Pain

Other Information

ATC CodeN/A
Related LinksN/A